|
Variable
|
GGT variation
|
AP variation
|
ALT variation
|
Bilirubin total variation
|
|---|
|
B [95% CI]
|
p
|
B [95% CI]
|
p
|
B [95% CI]
|
p
|
B [95% CI]
|
p
|
|---|
|
Surgery
|
1.05 [0.29–1.80]
|
0.007
|
0.18 [0.14–0.84]
|
0.006
| | |
2.00 [0.14–0.40]
|
0.014
|
|
Days in study
|
0.08 [0.03–0.13]
|
0.003
|
0.12 [0.18–0.17]
|
0.000
| | |
0.10 [−0.01–0.21]
|
0.072
|
|
Cancer
|
1.06 [0.27–1.84]
|
0.009
|
0.178 [−0.15–0.69]
|
0.060
| | | | |
|
Infection
|
0.44 [−0.01–0.88]
|
0.056
|
0.162 [0.04–0.68]
|
0.027
|
0.08 [0.01–0.16]
|
0.036
| | |
|
CRP
| | |
0.001 [0.00–0.006]
|
0.035
| | | | |
|
Leucocytes
| | | | | | |
0.15 [−0.12–0.29]
|
0.064
|
|
R2
|
0.150
| |
0.523
| |
0.050
| |
0.089
| |
- CI confidence interval (μkat/L), GGT Gamma-glutamyl transferase (μkat/L), AP Alkaline phosphatase (μkat/L), ALT Alanine aminotransferase; B: constant in the model R2 determination coefficient Creatinine, glucose and Intensive care unit stay do not feature in this model. Bold type indicates significance
- Bold means statistically significant
